| AIDS-Related Non-Hodgkin Lymphoma studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT01961063Phase 1 · active not recruiting Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649304Phase 1 · not yet recruiting AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Diffuse Large B-cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077527Phase 1 · recruiting Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337985Phase 1 · active not recruiting Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02823327terminated Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Primary Effusion Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595866Phase 1 · completed Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02199184Phase 2 · completed Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Burkitt Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193842Phase 1/Phase 2 · completed Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01775475Phase 2 · completed Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02378922Phase 1 · withdrawn Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (4 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769911NA · withdrawn Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158274Phase 1 · completed RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049036Phase 2 · completed Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005811Phase 2 · completed Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment · condition mapped ALIAS · 16 trials mapped (4 active) | — | — | AIDS-Related Immunoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |